The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss
组蛋白去乙酰化酶抑制剂伏立诺他可减少转移性骨部位的肿瘤生长和相关的骨溶解，但会促进正常骨丢失。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-10-0572
Pratap, Jitesh; Akech, Jacqueline; Wixted, John J; Szabo, Gabriela; Hussain, Sadiq; McGee-Lawrence, Meghan E; Li, Xiaodong; Bedard, Krystin; Dhillon, Robinder J; van Wijnen, Andre J; Stein, Janet L; Stein, Gary S; Westendorf, Jennifer J; Lian, Jane B
